News | June 28, 2012

BiO2 Medical Granted CE Mark for IVC Filter With a Prophylactic Use Indication


June 28, 2012 — BiO2 Medical Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colo., announced today that it has received CE mark approval for the Angel catheter, a nitinol inferior vena cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing pulmonary embolism (PE) in critically ill patients. This novel IVC filter/CVC combination device is the first IVC filter with a prophylactic use indication, and allows attending physicians the ability to place an IVC filter bedside in the Intensive Care Unit (ICU), in a procedure resembling a routine CVC placement procedure.

For more information: www.bio2medical.com

 

 


Related Content

News | Embolic Protection Devices

April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the ...

Home April 25, 2023
Home
News | Embolic Protection Devices

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

Home January 11, 2023
Home
News | Embolic Protection Devices

September 17, 2022 — Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial ...

Home September 17, 2022
Home
News | Embolic Protection Devices

February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke ...

Home February 09, 2021
Home
News | Embolic Protection Devices

August 6, 2019 — Cardiovascular Systems Inc. (CSI) has acquired the Wirion Embolic Protection System and related assets ...

Home August 06, 2019
Home
News | Embolic Protection Devices

July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round, raising ...

Home July 19, 2019
Home
News | Embolic Protection Devices

August 3, 2018 — Boston Scientific Corp. announced it has recently closed its acquisition of Claret Medical Inc., a ...

Home August 03, 2018
Home
News | Embolic Protection Devices

July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has ...

Home July 20, 2018
Home
News | Embolic Protection Devices

June 7, 2018 — The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used ...

Home June 07, 2018
Home
News | Embolic Protection Devices

May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of stroke ...

Home May 08, 2018
Home
Subscribe Now